{
    "organizations": [],
    "uuid": "0545e843915492765fa5739f9516a0703efd58e3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-alk-torii-secures-pricing-for-new/brief-alk-torii-secures-pricing-for-new-japanese-cedar-slit-tablet-idUSFWN1RV02X",
    "ord_in_thread": 0,
    "title": "BRIEF-ALK: Torii Secures Pricing For New Japanese Cedar Slit-Tablet",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 18 (Reuters) - ALK-ABELLO A/S:\n* ALK’S PARTNER FOR JAPAN, TORII, SECURES PRICING FOR NEW JAPANESE CEDAR SLIT-TABLET\n* TORII PHARMACEUTICAL SECURED A LISTING ON JAPAN’S NATIONAL HEALTH INSURANCE REIMBURSEMENT LIST FOR SLIT TABLET\n* LISTING CLEARS THE WAY FOR THE FORTHCOMING LAUNCH OF CEDARCURE, WHICH IS EXPECTED TO TAKE PLACE IN THE COMING MONTHS.\n* ALK IS ENTITLED TO RECEIVE ROYALTIES OF SALES OF CEDARCURE Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-18T13:06:00.000+03:00",
    "crawled": "2018-04-19T14:41:08.025+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "alk",
        "partner",
        "japan",
        "torii",
        "secures",
        "pricing",
        "new",
        "japanese",
        "cedar",
        "torii",
        "pharmaceutical",
        "secured",
        "listing",
        "japan",
        "national",
        "health",
        "insurance",
        "reimbursement",
        "list",
        "slit",
        "tablet",
        "listing",
        "clear",
        "way",
        "forthcoming",
        "launch",
        "cedarcure",
        "expected",
        "take",
        "place",
        "coming",
        "month",
        "alk",
        "entitled",
        "receive",
        "royalty",
        "sale",
        "cedarcure",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}